1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow QPI-1007 at various doses: new trials by email Literature Review of QPI-1007 at various doses trials Research Report on QPI-1007 at various doses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients QPI-1007 at various doses - Optic Atrophy, Non-arteritic Anterior Ischemic Optic Neuropathy | Phase 1 | Completed | Quark Pharmaceuticals | 48 | 2010-02-01 | 2013-05-13 |
Optic Atrophy (1) · Optic Atrophy, Hereditary, Leber (1) · Optic Neuritis (1) · Optic Neuropathy, Ischemic (1) · Retinal Degeneration (1)
Israel (1) · United States (1)
Rabia Ozden, MD (1)